Supportive Medicines including ITU, EOL & Antibiotics
key details
| Value | £96,000,000 |
|---|---|
| Status | cancelled |
| Category (CPV) | 33600000 |
| Deadline | 9 Aug 2020 |
| Contract start | 6 Nov 2020 |
| Contract end | 29 Jan 2021 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-501f0595-0cad-4496-974d-0b923821cd81 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| [ADMIN TEST] Stars and Stripes Ltd | £53,098,809 | 13 Sept 2020 | active |
description
A procurement exercise for supportive medicines that includes End of Life, Intensive Treatment Unit and Antibiotics medicines
documents
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kDwF/.l5RMky99eptxfZq6dbW7C0gOYoFsDN0888fc.C5Q5s , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kDwK/fhVbvicy_58if8suyzDsfL9jpF1lKnTokuUKTXv6REw , Link
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kDwL/LA1Cx4V_Bae8oR1bZQEh4QnCOJyHAdwPShCJpn3QgsM , Link
- https://www.contractsfinder.service.gov.uk/Notice/65c37bb9-9312-45a0-b67a-5b63bc40d04b , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 28 Oct 2020 | Tender cancelled (tenderCancellation) | · | 65c37bb9-9312-45a0-b67a-5b63bc40d04b-389747 |
more from Health Family
- XMNPROGYDC · £4,198,347 · 17 Mar 2021
- XMNPROGQ1P7 · £1,884,298 · 22 Feb 2021
- XMNPROGJANQ1P4 · £4,886,777 · 2 Feb 2021
- XMNPROGQ1P5 · £1,167,355 · 2 Feb 2021
- XMNPROGQ1P3 · £4,592,562 · 29 Jan 2021
- XMNPROGQ1 · £13,037,603 · 28 Jan 2021
- XMNPROGQ1P2 · £3,864,876 · 25 Jan 2021
- XMNPROGJAN3 · £1,301,653 · 21 Jan 2021
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.